Jiangsu GDK Biotechnology Co Ltd (688670) — Capital Reinvestment Ratio
Jiangsu GDK Biotechnology Co Ltd (688670) has a Capital Reinvestment Ratio of 1.58x as of December 2023, meaning it reinvests 2% of its operating cash flow (CN¥22.70 Million) in capital expenditures (CN¥35.83 Million). Check 688670 tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Jiangsu GDK Biotechnology Co Ltd Capital Reinvestment Ratio (2020–2023)
This chart tracks Jiangsu GDK Biotechnology Co Ltd's Capital Reinvestment Ratio across 4 annual periods. For the full cash flow conversion analysis, see 688670 operating cash flow.
Annual Capital Reinvestment Ratio for Jiangsu GDK Biotechnology Co Ltd (2020–2023)
Year-by-year Capital Reinvestment Ratio for Jiangsu GDK Biotechnology Co Ltd from 2020 to 2023. See Jiangsu GDK Biotechnology Co Ltd free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2023 | 0.67x | CN¥80.90 Million | CN¥54.00 Million | ▼ -84.7% |
| 2022 | 4.36x | CN¥38.60 Million | CN¥168.18 Million | ▲ +17.2% |
| 2021 | 3.72x | CN¥103.93 Million | CN¥386.39 Million | ▲ +897.2% |
| 2020 | 0.37x | CN¥109.46 Million | CN¥40.81 Million | — |